International Bulletin of Medical Sciences and Clinical Research
Clinical efficacy and safety profile of sodium cromoglycate 4% (lecrolin) in the treatment of allergic conjunctivitis
By Farkhatova Gulrukh.
Abstract
Allergic conjunctivitis is one of the most common ocular allergic disorders and represents a significant medical and quality-of-life burden. Increasing rates of sensitization to environmental allergens necessitate effective and well-tolerated topical therapies with pathogenetically targeted mechanisms of action. Sodium cromoglycate, a mast-cell stabilizing agent, has been used in the management of allergic ocular diseases for several decades.
Keywords
- Allergic Rhinitis and Sensitization
- disodium cromoglycate
- allergic conjunctivitis
- mast cell stabilizers
- topical ocular therapy
- drug efficacy
- drug safety
- ocular allergy
- Open access
Source
Published in International Bulletin of Medical Sciences and Clinical Research. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
